MTOR and non-small cell lung carcinoma: The combination of the autophagy inhibitor hydroxychloroquine with different drugs (gemcitabine, paclitaxel, carboplatin, etc.)or with mTOR inhibitors (rapamycin, everolimus, temsirolimus) is already used in several types of cancers, such as non-small cell lung cancer (NSCLC), pancreatic cancer, renal cell carcinoma, myeloma and squamous cell cancer (head and neck cancer) (Table 1).